Cannabinoid lozenge formulation
US11241413B2 · kind B2 · utility
0Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2020 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Apr 17, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a lozenge composition for controlled release of cannabinoids comprising; i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.